Muna oral pill shifts aging brain markers in trial
A Phase 1 study of MNA-001, which targets TREM2, saw age-linked markers in elderly volunteers shift toward levels seen in younger people. Researchers gave a pill to a group of elderly volunteers, then looked at the fluid around their brains and spinal cords. Some of the markers they found there had
<p>A Phase 1 study of MNA-001, which targets TREM2, saw age-linked markers in elderly volunteers shift toward levels seen in younger people. Researchers gave a pill to a group of elderly volunteers, then looked at the fluid around their brains and spinal cords. Some of the markers they found there had </p>